Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis

被引：0
|
作者：
T. Sugimoto
T. Nakamura
Y. Nakamura
Y. Isogai
M. Shiraki
机构：
[1] Shimane University,Internal Medicine 1, Faculty of Medicine
[2] National Center for Global Health and Medicine,Project for Bone Metabolic Disease
[3] Asahi Kasei Pharma Corporation,undefined
[4] Research Institute and Practice for Involutional Diseases,undefined
来源：
Osteoporosis International | 2014年 / 25卷
关键词：
Bone formation; Bone resorption; Calcium metabolism; Human; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1173 / 1180
页数：7
相关论文
共 50 条
  • [41] COMPARISON OF TRANSDERMAL AND SUBCUTANEOUS TERIPARATIDE EFFECTS ON MARKERS OF BONE TURNOVER AND SAFETY IN POSTMENOPAUSAL WOMEN
    Kenan, Y.
    Kochba, E.
    Shahar, M.
    Gadasi, H.
    Levin, G.
    Foldes, A. J.
    Ish-Shalom, S.
    Matsumoto, T.
    Lindsay, R.
    Christiansen, C.
    Neer, R.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 178 - 178
  • [42] Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial
    Anastasilakis, A. D.
    Goulis, D. G.
    Polyzos, S. A.
    Gerou, S.
    Koukoulis, G. N.
    Efstathiadou, Z.
    Kita, M.
    Avramidis, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (06) : 919 - 924
  • [43] The effects of once-weekly alendronate 70 mg on bone metabolism of postmenopausal women in Korea.
    Kim, H
    Shon, H
    Choi, J
    Lee, H
    Kim, E
    Park, I
    Park, I
    Kim, B
    Lee, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S394 - S394
  • [44] Response of markers of bone turnover and bone density to teriparatide in postmenopausal women previously treated with an antiresorptive drug
    Ettinger, B
    San Martin, J
    Crans, GG
    Pavo, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S15 - S15
  • [45] Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    D. Michalska
    M. Luchavova
    V. Zikan
    I. Raska
    A. A. Kubena
    J. J. Stepan
    Osteoporosis International, 2012, 23 : 2885 - 2891
  • [46] Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis
    Hong, Namki
    Kim, Jo Eun
    Lee, Su Jin
    Kim, Se Hwa
    Rhee, Yumie
    CLINICAL ENDOCRINOLOGY, 2018, 88 (05) : 652 - 658
  • [47] Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate
    Suwan, Ammarin
    Tanavalee, Chotetawan
    Panyakhamlerd, Krasean
    Ngarmukos, Srihatach
    Chavaengkiat, Suchanant
    Tanavalee, Aree
    Amarase, Chavarin
    Bumphenkiatikul, Thanapob
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [48] Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Michalska, D.
    Luchavova, M.
    Zikan, V.
    Raska, I., Jr.
    Kubena, A. A.
    Stepan, J. J.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (12) : 2885 - 2891
  • [49] The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk
    Sone, Teruki
    Ito, Masako
    Fukunaga, Masao
    Tomomitsu, Tatsushi
    Sugimoto, Toshitsugu
    Shiraki, Masataka
    Yoshimura, Takeshi
    Nakamura, Toshitaka
    BONE, 2014, 64 : 75 - 81
  • [50] Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol
    Shinichi Nakatoh
    Journal of Bone and Mineral Metabolism, 2018, 36 : 221 - 228
12345